CELZ vs USB · rev $11.0K vs P/E 12, rev $28.66B
Creative Medical Technology Holdings Inc (CELZ) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported CELZ revenue for 2024-12-31 was $11.0K. Net income was -$5.5M. Revenue was up 22.2% from 2023-12-31 to 2024-12-31. CELZ currently screens at market cap $8.3M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
CELZ currently screens at market cap $8.3M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the CELZ and USB stock pages for the full models.
Not investment advice.